MedTrace Logo

Evaluation of a Project to Distribute Water Filters and Cook Stoves in Western Rwanda--Phase 1B

NCT01998282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1035

Last updated 2017-03-13

No results posted yet for this study

Summary

DelAgua Health and Development, Manna Energy and the Rwanda Ministry of Health are collaborating on a project financed by carbon credits that will distribute household-based water filters and high-efficiency cook stoves to approximately 600,000 households in Rwanda. Prior to the full roll out of the campaign, the implementers are conducting research in connection with a distribution among 2000 households in western Rwanda. The objective of this matched cohort study (Phase 1B)are to investigate whether the filters and stoves delivered in October 2012 are still performing and in use, to determine whether they are associated with reductions in exposure to pathogens from drinking water and stoves, and to assembly information on health and other conditions necessary for the design of a large scale health impact evaluation.

Conditions

  • Focus of Study is to Assess Filter and Stove Use and Efficacy in Reducing Exposure to Waterborne and Airborne Pathogens

Sponsors & Collaborators

  • Ministry of Health, Rwanda

    collaborator OTHER_GOV

  • DelAgua

    collaborator OTHER

  • Portland State University

    collaborator OTHER

  • University of Colorado, Boulder

    collaborator OTHER

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Thomas F Clasen, PhD · London School of Hygiene and Tropical Medicine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Rwanda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01998282 on ClinicalTrials.gov